Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey

Kilickap, S.Ozturk, A.Karadurmus, N.Korkmaz, T.Yumuk, P.Cicin, I.Paydas, S.2024-06-122024-06-1220181556-08641556-1380https://hdl.handle.net/20.500.14551/22795[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessNSCLCALK InhibitorCrizotinibCrizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from TurkeyConference Object1310S477S478Q1WOS:000454014501235